MK-0966, a cyclooxygenase-2 (COX-2) specific inhibitor, had no effect on the anti-platelet activity of low-dose aspirin (ASA) measured by serum thromboxane B2 (TXB2) production and platelet aggregation.

被引：5

作者：

Greenberg, HE

Gillen, LP

Dorval, EP

Wildonger, L

Larson, P

Huntington, M

Wong, P

Gottesdiener, K

Waldman, SA

机构：

[1] Merck Res Labs, Rahway, NJ USA

[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

来源：

关键词：

D O I：

10.1016/S0009-9236(99)80184-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PII66

引用

页码：163 / 163

页数：1